VEKLURY

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Oct 22, 2020

   5 yr 9 mo ago

2. Exclusivity ends · NCE

   New chemical entity exclusivity (5 years)

   Oct 22, 2025

   8 mo ago

3. Exclusivity ends · PED

   Pediatric exclusivity (adds 6 months)

   Apr 22, 2026

   2 mo ago

4. Today

5. Exclusivity ends · M-301

   New use / labeling-change exclusivity (3 years)

   Jul 13, 2026

   in 24 d

6. Exclusivity ends · PED

   Pediatric exclusivity (adds 6 months)

   Jan 13, 2027

   in 7 mo

7. Patent 8318682 expires

   Listed drug substance patent expiration.

   Apr 22, 2029

   in 2 yr 11 mo

8. Patent RE46762 expires

   Listed drug substance patent expiration.

   Apr 22, 2029

   in 2 yr 11 mo

9. Patent 8008264 expires

   Listed drug substance patent expiration.

   Sep 06, 2029

   in 3 yr 3 mo

10. Patent 8318682*PED expires

    Listed listed patent expiration.

    Oct 22, 2029

    in 3 yr 5 mo

11. Patent RE46762*PED expires

    Listed listed patent expiration.

    Oct 22, 2029

    in 3 yr 5 mo

12. Patent 8008264*PED expires

    Listed listed patent expiration.

    Mar 06, 2030

    in 3 yr 9 mo

13. Patent 10065958 expires

    Listed drug substance patent expiration.

    Sep 16, 2031

    in 5 yr 4 mo

14. Patent 11492353 expires

    Listed drug substance patent expiration.

    Dec 08, 2031

    in 5 yr 7 mo

15. Patent 10065958*PED expires

    Listed listed patent expiration.

    Mar 16, 2032

    in 5 yr 10 mo

16. Patent 11492353*PED expires

    Listed listed patent expiration.

    Jun 08, 2032

    in 6 yr 1 mo

17. Patent 9724360 expires

    Listed drug substance patent expiration.

    Oct 29, 2035

    in 9 yr 6 mo

18. Patent 9949994 expires

    Listed drug substance patent expiration.

    Oct 29, 2035

    in 9 yr 6 mo

19. Patent 9724360*PED expires

    Listed listed patent expiration.

    Apr 29, 2036

    in 10 yr

20. Patent 9949994*PED expires

    Listed listed patent expiration.

    Apr 29, 2036

    in 10 yr

21. Patent 10695361 expires

    Listed method-of-use patent (U-3831) expiration.

    Sep 16, 2036

    in 10 yr 5 mo

22. Patent 10695361 expires

    Listed method-of-use patent (U-3832) expiration.

    Sep 16, 2036

    in 10 yr 5 mo

23. Patent 11007208 expires

    Listed method-of-use patent (U-3831) expiration.

    Sep 16, 2036

    in 10 yr 5 mo

24. Patent 11007208 expires

    Listed method-of-use patent (U-3832) expiration.

    Sep 16, 2036

    in 10 yr 5 mo

25. Patent 11382926 expires

    Listed method-of-use patent (U-3831) expiration.

    Sep 16, 2036

    in 10 yr 5 mo

26. Patent 11382926 expires

    Listed method-of-use patent (U-3832) expiration.

    Sep 16, 2036

    in 10 yr 5 mo

27. Patent 10695361*PED expires

    Listed listed patent expiration.

    Mar 16, 2037

    in 10 yr 11 mo

28. Patent 11007208*PED expires

    Listed listed patent expiration.

    Mar 16, 2037

    in 10 yr 11 mo

29. Patent 11382926*PED expires

    Listed listed patent expiration.

    Mar 16, 2037

    in 10 yr 11 mo

30. Patent 10675296 expires

    Listed drug product patent expiration.

    Jul 10, 2038

    in 12 yr 3 mo

31. Patent 11266681 expires

    Listed method-of-use patent (U-3832) expiration.

    Jul 10, 2038

    in 12 yr 3 mo

32. Patent 11266681 expires

    Listed method-of-use patent (U-3831) expiration.

    Jul 10, 2038

    in 12 yr 3 mo

33. Patent 11975017 expires

    Listed drug product patent expiration.

    Jul 10, 2038

    in 12 yr 3 mo

34. Patent 10675296*PED expires

    Listed listed patent expiration.

    Jan 10, 2039

    in 12 yr 9 mo

35. Patent 11266681*PED expires

    Listed listed patent expiration.

    Jan 10, 2039

    in 12 yr 9 mo

36. Patent 11975017*PED expires

    Listed listed patent expiration.

    Jan 10, 2039

    in 12 yr 9 mo

37. Patent 11491169 expires

    Listed method-of-use patent (U-3836) expiration.

    May 28, 2041

    in 15 yr 2 mo

38. Patent 11491169 expires

    Listed method-of-use patent (U-3835) expiration.

    May 28, 2041

    in 15 yr 2 mo

39. Patent 11903953 expires

    Listed method-of-use patent (U-3835) expiration.

    May 28, 2041

    in 15 yr 2 mo

40. Patent 11903953 expires

    Listed method-of-use patent (U-3836) expiration.

    May 28, 2041

    in 15 yr 2 mo

41. Patent 11975012 expires

    Listed method-of-use patent (U-3835) expiration.

    May 28, 2041

    in 15 yr 2 mo

42. Patent 11975012 expires

    Listed method-of-use patent (U-3836) expiration.

    May 28, 2041

    in 15 yr 2 mo

43. Patent 11491169*PED expires

    Listed listed patent expiration.

    Nov 28, 2041

    in 15 yr 8 mo

44. Patent 11903953*PED expires

    Listed listed patent expiration.

    Nov 28, 2041

    in 15 yr 8 mo

45. Patent 11975012*PED expires

    Listed listed patent expiration.

    Nov 28, 2041

    in 15 yr 8 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (4)

• NCENew chemical entity exclusivity (5 years)

  Oct 22, 2025

  8 mo ago

• PEDPediatric exclusivity (adds 6 months)

  Apr 22, 2026

  2 mo ago

• M-301New use / labeling-change exclusivity (3 years)

  Jul 13, 2026

  in 24 d

• PEDPediatric exclusivity (adds 6 months)

  Jan 13, 2027

  in 7 mo

Listed patents (39)